"Food-Drug Interactions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The pharmacological result, either desirable or undesirable, of drugs interacting with components of the diet. (From Stedman, 25th ed)
| Descriptor ID |
D018565
|
| MeSH Number(s) |
G07.690.773.968.511
|
| Concept/Terms |
Food-Drug Interactions- Food-Drug Interactions
- Food Drug Interactions
- Food-Drug Interaction
- Interaction, Food-Drug
- Interactions, Food-Drug
- Drug-Food Interactions
- Drug Food Interactions
- Drug-Food Interaction
- Interaction, Drug-Food
- Interactions, Drug-Food
Food Interactions- Food Interactions
- Food Interaction
- Interaction, Food
- Interactions, Food
|
Below are MeSH descriptors whose meaning is more general than "Food-Drug Interactions".
Below are MeSH descriptors whose meaning is more specific than "Food-Drug Interactions".
This graph shows the total number of publications written about "Food-Drug Interactions" by people in this website by year, and whether "Food-Drug Interactions" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2002 | 1 | 1 | 2 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Food-Drug Interactions" by people in Profiles.
-
A randomized trial of safety and pharmacodynamic interactions between a selective glucocorticoid receptor antagonist, PT150, and ethanol in healthy volunteers. Sci Rep. 2021 05 10; 11(1):9876.
-
Phase I study of DFP-11207, a novel oral fluoropyrimidine with reasonable AUC and low Cmax and improved tolerability, in patients with solid tumors. Invest New Drugs. 2020 12; 38(6):1763-1773.
-
Bioavailability of aspirin in fasted and fed states of a novel pharmaceutical lipid aspirin complex formulation. J Thromb Thrombolysis. 2020 Apr; 49(3):337-343.
-
Review of nutritional status, body composition, and effects of antineoplastic drug disposition. Pediatr Blood Cancer. 2020 06; 67 Suppl 3:e28207.
-
Drug-development concepts as guides for optimizing clinical trials of supplemental zinc for populations at risk of deficiency or diarrhea. Nutr Rev. 2017 03 01; 75(3):147-162.
-
Clinical pharmacology characterization of RG7112, an MDM2 antagonist, in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2015 Sep; 76(3):587-95.
-
Switching from posaconazole suspension to tablets increases serum drug levels in leukemia patients without clinically relevant hepatotoxicity. Antimicrob Agents Chemother. 2014 Nov; 58(11):6993-5.
-
Calcium carbonate does not affect nilotinib pharmacokinetics in healthy volunteers. Cancer Chemother Pharmacol. 2013 Nov; 72(5):1143-7.
-
Complications of anticoagulation. Dis Mon. 2012 Aug; 58(8):440-7.
-
Antagonistic effect of flavonoids on NSC-741909-mediated antitumor activity via scavenging of reactive oxygen species. Eur J Pharmacol. 2010 Dec 15; 649(1-3):51-8.